CTNNB1 and Cirrhosis: On the other hand, patients who did not harbor CTNNB1 mutations showed significantly higher LECT2 level (54.26±22.25 ng/mL; n = 46) than those with cirrhosis and from healthy volunteers (p = 0.0044 and 0.0176, respectively) (Figure 3A).